menu
    • menu

    Company profile for March Biosciences

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    March Biotech is pioneering advancements in synthetic biology to develop sustainable solutions for global health and environmental challenges. Focused on harnessing the power of engineered microbes, March Biotech creates innovative biotechnological platforms that offer sustainable alternatives across sectors like pharmaceuticals, agriculture, and materials. By combining cutting-edge research with a commitment to ecological res...
    March Biotech is pioneering advancements in synthetic biology to develop sustainable solutions for global health and environmental challenges. Focused on harnessing the power of engineered microbes, March Biotech creates innovative biotechnological platforms that offer sustainable alternatives across sectors like pharmaceuticals, agriculture, and materials. By combining cutting-edge research with a commitment to ecological responsibility, March Biotech is driving a future where biotechnology addresses pressing global needs while fostering environmental harmony.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    March BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    7255 Helix Parke Ave Suite 300 Houston, TX 77030
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://march.bio/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    March Biosciences Unveils Positive Phase 2 MB-105 CD5 CAR-T
    March Biosciences Unveils Positive Phase 2 MB-105 CD5 CAR-T

    08 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/08/3201704/0/en/March-Biosciences-Presents-Positive-Interim-Clinical-Data-from-Phase-2-Trial-of-MB-105-CD5-CAR-T-Cell-Therapy-at-ASH-2025-Annual-Meeting.html

    GLOBENEWSWIRE
    08 Dec 2025
    Share Share
    March Biosciences Names Gurpreet Ratra as Chief Business Officer
    March Biosciences Names Gurpreet Ratra as Chief Business Officer

    03 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/03/3198801/0/en/March-Biosciences-Announces-Appointment-of-Gurpreet-Ratra-Ph-D-as-Chief-Business-Officer.html

    GLOBENEWSWIRE
    03 Dec 2025
    Share Share
    March Biosciences Granted FDA RMAT Designation For MB-105
    March Biosciences Granted FDA RMAT Designation For MB-105

    11 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/11/3185372/0/en/March-Biosciences-Receives-FDA-Regenerative-Medicine-Advanced-Therapy-RMAT-Designation-for-MB-105-in-Relapsed-Refractory-CD5-Positive-T-Cell-Lymphoma.html

    GLOBENEWSWIRE
    11 Nov 2025
    Share Share
    March Biosciences Presents MB-105 Phase 2 Interim Data at ASH
    March Biosciences Presents MB-105 Phase 2 Interim Data at ASH

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179365/0/en/March-Biosciences-Announces-Oral-Presentation-of-MB-105-Interim-Phase-2-Clinical-Data-at-American-Society-of-Hematology-Annual-Meeting.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share
    March Biosciences Starts Phase 2 Trial of CD5 CAR-T for Lymphoma
    March Biosciences Starts Phase 2 Trial of CD5 CAR-T for Lymphoma

    22 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/22/3065415/0/en/March-Biosciences-Announces-First-Patient-Dosed-in-Phase-2-Clinical-Trial-of-MB-105-First-in-Class-CD5-CAR-T-Cell-Therapy-for-T-Cell-Lymphoma.html

    GLOBENEWSWIRE
    22 Apr 2025
    Share Share
    March Bio FDA Orphan Drug Designation For MB-105 In T-Cell Lymphoma
    March Bio FDA Orphan Drug Designation For MB-105 In T-Cell Lymphoma

    28 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/28/3016342/0/en/March-Biosciences-Receives-FDA-Orphan-Drug-Designation-for-MB-105-a-First-in-Class-CD5-CAR-T-Cell-Therapy-for-T-Cell-Lymphoma.html

    GLOBENEWSWIRE
    28 Jan 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search